In one paragraphArticle in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Takaya SasakiThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0001-9525-2638 Luke BuizenThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
Katie HarrisThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
Sunil V BadveThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0003-2269-312 John ChalmersThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0002-9931-0580 Martin GallagherThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0001-9187-6187 Jeffrey T HaThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0002-8558-1697 Meg J JardineThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0002-0160-2375 Daniel B KetemaThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0002-7464-7814 Sradha S KotwalThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0002-3294-4087 Brendon L NeuenThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0001-9276-8380 Hannah WallaceThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0002-2728-4299 Takashi YokooDivision of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.ORCID 0000-0003-1838-7998 Mark WoodwardThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0001-9800-5296 Min JunThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0003-1460-7535 Funding
University of New South Wales Scientia Program, Boehringer Ingelheim and Eli Lilly Alliance
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
chronic kidney failureCKDESKDGFRkidney dysfunctionkidney failuremortalitymortality riskrenal function
Identifiers
PMID41143921
PMCPMC12935336
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390